A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants
NCT07308236 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2026-03-05
Summary
The primary purpose of this study is to determine the metabolism and excretion of \[14C\]E2086 in healthy male participants.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
E2086
E2086 oral capsule.
Sponsors & Collaborators
-
Eisai Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-31
- Primary Completion
- 2026-02-23
- Completion
- 2026-02-23
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2027 in Healthy Subjects
NCT02873156 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of E8001 in Healthy Male Participants
NCT04609852 ·Status: COMPLETED ·Phase: PHASE1
-
Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects
NCT02268838 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
NCT04666922 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Intravenous Dose of E3112 in Japanese Healthy Adult Male Participants
NCT03922633 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase Ia Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of EA5 in Healthy Adult Subjects
NCT07256288 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742 in Healthy Adult Subjects
NCT03082235 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body
NCT03173625 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants
NCT04223960 ·Status: COMPLETED ·Phase: PHASE1
-
MT1013 Clinical TRIAL In Healthy Subject
NCT04783090 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Single Ascending Doses of PF-07258669 in Healthy Adult Participants
NCT04628793 ·Status: COMPLETED ·Phase: PHASE1
-
A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects
NCT02039089 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2730 in Healthy Participants
NCT03451890 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of NPC-22 in Healthy Adult Males
NCT04203862 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers
NCT00726427 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers
NCT01634529 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects
NCT03869320 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men
NCT03349723 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects
NCT02289599 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants
NCT06877702 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers
NCT07279636 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects
NCT02415790 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese Males
NCT00722202 ·Status: COMPLETED ·Phase: PHASE1
-
Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL
NCT02268136 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers
NCT01489306 ·Status: COMPLETED ·Phase: PHASE1